C9orf72 and amyotrophic lateral sclerosis: The recent developments in C9orf72 ASOs and CRISPR technologies, together with treatment strategies that address the consequences of C9orf72-driven ALS, represent a comprehensive approach to treating both the cause and consequence of C9orf72-driven ALS [165].